A carregar...
Selegiline: a molecule with innovative potential
Monoamine oxidase B (MAO-B) inhibitors have an established role in the treatment of Parkinson’s disease as monotherapy or adjuvant to levodopa. Two major recognitions were required for their introduction into this therapeutic field. The first was the elucidation of the novel pharmacological properti...
Na minha lista:
| Publicado no: | J Neural Transm (Vienna) |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Vienna
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7242272/ https://ncbi.nlm.nih.gov/pubmed/31562557 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00702-019-02082-0 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|